Agenda – Value-Based Strategies for Reimbursement & Formulary Success

  • Day One
  • Day Two

Day One

 Monday, November 6, 2017

 EXAMINING THE VALUE-BASED HEALTHCARE LANDSCAPE

9:15AM – 10:00AM

Examine What Is Right and What Is Wrong With Prescription Drug Pricing, Cost and Affordability in the United States
Robert Popovian, Pharm.D., Vice President, U.S. Government Relations, PFIZER

10:00AM – 10:45AM

Leverage Internal and External Collaboration to Position Your Product/Procedure in a Value Based Healthcare Environment
Natalie Heidrich, M.S., Field Director, Health Economics Market Access, JOHNSON & JOHNSON MEDICAL DEVICE COMPANIES

10:45AM – 11:15AM

Networking Break

 DEVELOPING VALUE-PROPOSITIONS

11:15AM – 12:00PM

Tailor Value Propositions to Meet an Institution’s Needs, One Question at a Time
Aaron Shaw, RN-BSN, Director, Medical Affairs | Digital Innovation, Pacira Pharmaceuticals, Inc

12:00PM – 12:45PM

PANEL: Develop Value Propositions to Reflect Patient Needs
Sachin Kamal-Bahl, Vice President and Innovation Center Head, Global Health & Value, PFIZER
Melissa L. Paige, Oncology Patient Access Principal Coordinator, UNIVERSITY OF VIRGINIA HEALTH SYSTEM, NCI-DESIGNATED EMILY COURIC CLINICAL CANCER CENTER

12:45PM – 1:45PM

Luncheon

 VALUE-BASED CONTRACTING

1:45PM – 2:30PM

Navigate Unchartered Waters With Value-Based Purchasing for Manufacturers
David Byram, Former Vice President, Market Access, and Government Affairs, Braeburn Pharmaceuticals

2:30PM – 3:15PM

Review Best Practices in Value-Based Contracting for Pharmaceuticals
Wanmei Ou, Ph.D., Director, Precision Medicine & Data Science, Center for Observational and Real-World Evidence, MERCK & CO.

3:15PM – 3:45PM

Networking Break

3:45PM – 4:30PM

Gain New Understanding of the Role of Real-World Data in Value-Based Payments
Melinda Hanisch, Director, Research Dissemination, Center for Observational and Real-World Evidence, MERCK & CO.

4:30PM – 5:15PM

Best Practices in Early Market Access Strategy Development
Rob Laverty, Vice President, Market Access, OTSUKA PHARMACEUTICAL COMPANIES

5:15PM – 5:15PM

Day One Concludes


Day Two

 Tuesday, November 7, 2017

 ALIGNING WITH PAYERS

9:15AM – 10:00AM

Inspect the Payer Spider Web to Determine How to Dissect, Evaluate, and Develop a Comprehensive Strategy
Greg Wujek, Vice President, Market Access, Castle Creek Pharma

10:00AM – 10:45AM

Establish Early Payer Strategies for Rare Disease Products
Raquel Cabo, Vice President, Global Market Access, OVID THERAPEUTICS

10:45AM – 11:15AM

Networking Break

11:15AM – 12:00PM

Develop Evidence for Pharma-Payer Partnerships
Jesse Fishman, Scientific Alliance and Real-World Data Lead, UCB

12:00PM – 12:45PM

PANEL: Strategically Align Goals and Objectives With Payers to Optimize Value-Based Arrangements
Greg Wujek, Vice President, Market Access, Castle Creek Pharma
Jesse Fishman, Scientific Alliance and Real-World Data Lead, UCB
Aaron Shaw, RN-BSN, Director, Medical Affairs | Digital Innovation, Pacira Pharmaceuticals, Inc

12:45PM – 1:45PM

Luncheon

 EXPANDING MARKET ACCESS

1:45PM – 2:30PM

Define Strategies to Ensure Market Access for Vulnerable Populations
Timothy Mizak, Pharm.D., Manager, Clinical Operations and Value-Based Purchasing, GATEWAY HEALTH PLAN

2:30PM – 3:15PM

Explore Day-to-Day Access Barriers at Various Levels That Impact the Time From Prescribed to On-Therapy
Melissa L. Paige, Oncology Patient Access Principal Coordinator, UNIVERSITY OF VIRGINIA HEALTH SYSTEM, NCI-DESIGNATED EMILY COURIC CLINICAL CANCER CENTER

3:45PM – 3:45PM

Conference Concludes